Analystreport

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.

Lexicon Pharmaceuticals, Inc.  (LXRX) 
Last lexicon pharmaceuticals, inc. earnings: 4/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: lexpharma.com/investors